The investment objective of the scheme is to provide returns that, before expenses, correspond to the total returns of the securities as represented by S&P BSE Low Volatility Total Return Index, subject to tracking error.
Expert-managed portfolios tailored to your financial goals and risk appetite.
| ETFs | 1M | 3M | 6M | 9M | 1Y | 2Y | 3Y | 4Y | 5Y | 10Y | ALL |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund returns | -3.97% | -8.47% | -7.05% | -12.16% | -12.26% | -6.42% | 5.62% | 9.31% | N/A | N/A | 9.22% |
| Category returns | -2.99% | -4.52% | -3.02% | -5.03% | -4.77% | -2.03% | 9% | 10.98% | 7.45% | 11.5% | N/A |
| Absolute returns | -3.97% | -8.47% | -7.05% | -12.16% | -12.26% | -12.45% | 17.84% | 42.79% | N/A | N/A | 49.75% |
| Rank within category | 150/268 | 242/252 | 215/241 | 209/228 | 195/207 | 138/162 | 105/134 | 53/112 | N/A | N/A | N/A |
| ETFs | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Yearly returns | N/A | 29.91% | 11.34% | 8.25% | -13.37% |
| Q1 returns | N/A | -2.23% | 7.86% | -2.52% | -12.8% |
| Q2 returns | -3.62% | 11.22% | 7.22% | 8.95% | 7.46% |
| Q3 returns | 8.4% | 5.06% | 8.22% | -3.2% | -6.64% |
| Q4 returns | 5.21% | 13.72% | -11.04% | 5.3% | -0.98% |
| Alpha | 0.0361793 |
| Beta | 0.9348 |
| Sharpe Ratio | 0.0264729 |
| Sortino Ratio | 0.0452678 |
| R-Squared | 0.8305 |
| Tracking Error | 1.5251 |
| Downside Risk | 20.3438 |
| Std. Deviation (Annualised) | 12.7629 |
| ETFs | 1M | 3M | 6M | 9M | 1Y | 3Y | 5Y | 10Y | ALL | Fund Size (Cr) | Exp. Ratio | Sharpe | Risk |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Motilal Oswal BSE Healthcare ETF | -7.16% | -4.01% | 10.11% | 12.75% | 6.7% | 19.48% | N/A | N/A | 19.41% | 44.40 | 0.36 | 0.30 | Very High |
| Nippon India Nifty Pharma ETF | -4.12% | -0.09% | 14.11% | 16.17% | 15.52% | 19.28% | 12.79% | N/A | 12.07% | 1,736.44 | 0.23 | 0.30 | Very High |
| Motilal Oswal BSE Enhanced Value ETF | -3.37% | -6.03% | -9.38% | -9.5% | -0.01% | 18.7% | N/A | N/A | 26.28% | 146.61 | 0.43 | 0.20 | Very High |
| DSP Nifty PSU Bank ETF | -0.29% | -1.08% | -5.84% | -7.11% | 9.24% | 18.66% | N/A | N/A | 20.49% | 1,434.17 | 0.16 | 0.15 | Very High |
| ICICI Prudential Nifty PSU Bank ETF | -0.32% | -1.15% | -6.01% | -7.33% | 8.91% | 18.53% | N/A | N/A | 26.2% | 118.61 | 0.41 | 0.15 | Very High |
| Nippon India ETF Nifty PSU Bank BeES | -0.32% | -1.17% | -6.04% | -7.39% | 8.81% | 18.35% | 25.56% | 10.01% | 6.93% | 3,932.00 | 0.51 | 0.14 | Very High |
| Kotak Nifty PSU Bank ETF | -0.32% | -1.17% | -6.06% | -7.4% | 8.79% | 18.33% | 25.56% | 9.94% | 6.36% | 2,490.74 | 0.51 | 0.14 | Very High |
| Aditya Birla Sun Life Nifty Healthcare ETF | -6.38% | -4.45% | 7.53% | 9.15% | 4.95% | 18.01% | 0% | N/A | 12.85% | 74.67 | 0.20 | 0.27 | Very High |
| ICICI Prudential Nifty Healthcare ETF | -6.38% | -4.44% | 7.56% | 9.19% | 5% | 17.87% | 12.38% | N/A | 12.86% | 231.43 | 0.16 | 0.27 | Very High |
| Motilal Oswal BSE Low Volatility ETF Current | -3.97% | -8.47% | -7.05% | -12.16% | -12.26% | 5.62% | N/A | N/A | 9.22% | 69.29 | 0.56 | 0.03 | Very High |
| Name | Sector | Instrument | Assets % |
|---|---|---|---|
| Castrol India Ltd. | Petroleum Products | Domestic Equities | 4.96% |
| Net Receivables / (Payables) | Cash & Cash Equivalents and Net Assets | 4.48% | |
| Marico Ltd. | Agricultural Food & other Products | Domestic Equities | 3.66% |
| Abbott India Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.63% |
| Apollo Hospitals Enterprise Ltd. | Healthcare Services | Domestic Equities | 3.49% |
| ITC Ltd. | Diversified FMCG | Domestic Equities | 3.48% |
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.46% |
| NTPC Ltd. | Power | Domestic Equities | 3.43% |
| Bharti Airtel Ltd. | Telecom - Services | Domestic Equities | 3.43% |
| SBI Life Insurance Company Ltd. | Insurance | Domestic Equities | 3.42% |
| HDFC Bank Ltd. | Banks | Domestic Equities | 3.39% |
| ICICI Bank Ltd. | Banks | Domestic Equities | 3.37% |
| Kotak Mahindra Bank Ltd. | Banks | Domestic Equities | 3.35% |
| Power Grid Corporation Of India Ltd. | Power | Domestic Equities | 3.26% |
| Lupin Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.25% |
| Tata Power Company Ltd. | Power | Domestic Equities | 3.23% |
| Alkem Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.20% |
| Cipla Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.18% |
| HDFC Life Insurance Company Ltd. | Insurance | Domestic Equities | 3.13% |
| Britannia Industries Ltd. | Food Products | Domestic Equities | 3.12% |
| Reliance Industries Ltd. | Petroleum Products | Domestic Equities | 3.11% |
| Nestle India Ltd. | Food Products | Domestic Equities | 3.10% |
| Procter & Gamble Hygiene and Health Care Ltd. | Personal Products | Domestic Equities | 3.09% |
| Shree Cement Ltd. | Cement & Cement Products | Domestic Equities | 3.08% |
| Hindustan Unilever Ltd. | Diversified FMCG | Domestic Equities | 3.06% |
| Pidilite Industries Ltd. | Chemicals & Petrochemicals | Domestic Equities | 3.06% |
| Coal India Ltd. | Consumable Fuels | Domestic Equities | 2.96% |
| ACC Ltd. | Cement & Cement Products | Domestic Equities | 2.89% |
| Grasim Industries Ltd. | Cement & Cement Products | Domestic Equities | 2.88% |
| United Breweries Ltd. | Beverages | Domestic Equities | 2.85% |
| Total | 100.00% | ||
Mr. Swapnil Mayekar has more than 10 years of overall experience in the financial services industry. He has been part of fund management & product development team for Motilal Oswal Asset Management Company Ltd. Mr. Mayekar's key area of expertise is trading in equity and debt segment, quantitative analysis, creating customized indices, model testing and building research database. His last assignment was with Business Standard Limited as a Research Associate. He has done his post-graduation in Commerce (Finance Management) from University of Mumbai.
Mr. Rakesh Shetty has more than 13 years of overall experience and expertise in trading in equity, debt segment, Exchange Trade Fund’s management, Corporate Treasury and Banking. Prior to joining Motilal Oswal Asset Management Company Limited, he has worked with Company engaged in Capital Market Business wherein he was in charge of equity and debt ETFs, customized indices and has also been part of product development.
Mr. Dishant Mehta has more than 9 years of experience and expertise in Financial markets across different segment- Equities, Derivatives, Commodities and Currencies. Managed Institutional and Foreign Portfolio Investment clients.
Get personalized portfolio management services designed to grow and protect your wealth.
ChatGPT
Claude
Perplexity
